Stan Berenshteyn
Stock Analyst at Wells Fargo
(2.18)
# 1,493
Out of 4,415 analysts
43
Total ratings
50%
Success rate
-6%
Average return
Main Sectors:
Top Industries:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDRX GoodRx Holdings | Upgrades: Overweight | $10 | $7.10 | +40.85% | 6 | Mar 25, 2024 | |
| OMCL Omnicell | Maintains: Equal-Weight | $28 → $26 | $29.29 | -11.23% | 9 | Feb 9, 2024 | |
| DOCS Doximity | Maintains: Equal-Weight | $25 → $27 | $24.09 | +12.08% | 6 | Feb 9, 2024 | |
| ACCD Accolade | Maintains: Equal-Weight | $10 → $12 | $7.26 | +65.29% | 7 | Jan 9, 2024 | |
| HQY HealthEquity | Maintains: Overweight | $89 → $93 | $79.75 | +16.61% | 6 | Dec 6, 2023 | |
| VEEV Veeva Systems | Upgrades: Overweight | $211 → $229 | $203.45 | +12.56% | 3 | Oct 25, 2023 | |
| HCAT Health Catalyst | Upgrades: Overweight | $13 → $16 | $6.48 | +146.91% | 3 | Apr 4, 2023 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $28 → $23 | $12.78 | +79.97% | 2 | Mar 6, 2023 | |
| AMWL American Well | Maintains: Equal-Weight | $6 → $4 | $0.57 | +601.75% | 1 | Feb 28, 2022 |
GoodRx Holdings
Mar 25, 2024
Upgrades: Overweight
Price Target: $10
Current: $7.10
Upside: +40.85%
Omnicell
Feb 9, 2024
Maintains: Equal-Weight
Price Target: $28 → $26
Current: $29.29
Upside: -11.23%
Doximity
Feb 9, 2024
Maintains: Equal-Weight
Price Target: $25 → $27
Current: $24.09
Upside: +12.08%
Accolade
Jan 9, 2024
Maintains: Equal-Weight
Price Target: $10 → $12
Current: $7.26
Upside: +65.29%
HealthEquity
Dec 6, 2023
Maintains: Overweight
Price Target: $89 → $93
Current: $79.75
Upside: +16.61%
Veeva Systems
Oct 25, 2023
Upgrades: Overweight
Price Target: $211 → $229
Current: $203.45
Upside: +12.56%
Health Catalyst
Apr 4, 2023
Upgrades: Overweight
Price Target: $13 → $16
Current: $6.48
Upside: +146.91%
Teladoc Health
Mar 6, 2023
Maintains: Equal-Weight
Price Target: $28 → $23
Current: $12.78
Upside: +79.97%
American Well
Feb 28, 2022
Maintains: Equal-Weight
Price Target: $6 → $4
Current: $0.57
Upside: +601.75%